Health Dictionary
Reliable, easy-to-read patient information on common medical conditions — written in plain language, free of jargon, and grounded in current evidence. Browse the most frequent diagnoses, understand what they mean for everyday life, and learn which steps and questions help you have a focused conversation with your doctor.
Undifferentiated connective tissue disease medical therapy
Introduction
Overview
Overview
The pharmacologic medical therapy is recommended based on the rheumatic disease pattern manifested by the patient such as methotrexate in those exhibiting arthritis and dermatitis. Supportive therapy includes; avoiding cold exposure in those experiencing Raynaud’s phenomenon, avoiding sun in photosensitivity, non-steroidal anti-inflammatory drugs for pain control, sunscreen used for photosensitivity, and emollients for dry skin and rash.
Medical Therapy
Medical Therapy
Routine measures
- Avoiding cold exposure in those experiencing Raynaud’s phenomenon
- Avoiding sun in photosensitivity
Supportive therapy
- Non-steroidal anti-inflammatory drugs for pain control
- Sunscreen used for photosensitivity
- Emollients for dry skin, rash
Arthritis and dermatitis
- Oral regimen
- Preferred regimen (1): Methotrexate 7.5 mg PO q24h for 6 months (not used for CNS symptoms or serositis)[1]
- Dose can be gradually increased to 13.6 mg after 6 months
- Preferred regimen (1): Methotrexate 7.5 mg PO q24h for 6 months (not used for CNS symptoms or serositis)[1]
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Amandeep Singh M.D.[2]